ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.524,37
0,50%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Applied Therapeutics Inc (APLT)

  7. Applied Therapeutics Inc (APLT) News

APLT Applied Therapeutics Inc

4,67
-0,59 (-11,22%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Applied Therapeutics Inc APLT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,59 -11,22% 4,67 06:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,23 4,93 5,28 5,05 5,26
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.6.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.6.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.6.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202422:25EDGAR2Form 8-K - Current report
05.6.202422:26EDGAR2Form 144 - Report of proposed sale of securities
04.6.202422:31EDGAR2Form 144 - Report of proposed sale of securities
17.5.202422:37EDGAR2Form 144 - Report of proposed sale of securities
17.5.202400:10EDGAR2Form 144 - Report of proposed sale of securities
09.5.202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202413:13EDGAR2Form 8-K - Current report
09.5.202413:00GLOBEApplied Therapeutics Reports First Quarter 2024 Financial..
07.5.202413:00GLOBEApplied Therapeutics to Present at the 2024 RBC Capital..
15.4.202413:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04.4.202413:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28.3.202421:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11.3.202413:17EDGAR2Form 8-K - Current report
06.3.202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06.3.202413:12EDGAR2Form 8-K - Current report
06.3.202413:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05.3.202423:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29.2.202422:18EDGAR2Form 8-K - Current report
28.2.202414:05GLOBEApplied Therapeutics Announces $100 Million Private..
28.2.202414:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22.2.202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15.2.202413:07EDGAR2Form 8-K - Current report
15.2.202413:00GLOBEApplied Therapeutics Announces Positive Results from..
15.2.202403:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.1.202423:02EDGAR2Form 8-K - Current report
04.1.202422:05GLOBEApplied Therapeutics Announces Topline Results from the..
03.1.202417:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03.1.202415:15EDGAR2Form 8-K - Current report
03.1.202413:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29.12.202322:23EDGAR2Form 8-K - Current report
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:11EDGAR2Form 8-K - Current report
13.11.202323:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09.11.202313:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202313:36EDGAR2Form 8-K - Current report
09.11.202313:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03.11.202321:37EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
APLT
Applied Therapeutics
USOTC
TBGRF
Bank Of Greenland AS (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten